Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Hims & Hers Health's share price for the quarter that ended in Jun. 2026 was $34.67. Hims & Hers Health's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 233 Mil. Therefore, Hims & Hers Health's market cap for the quarter that ended in Jun. 2026 was $8,088 Mil.
Hims & Hers Health's quarterly market cap
declined
from Dec. 2025 ($7,379 Mil) to Mar. 2026 ($4,789 Mil) but then
increased
from Mar. 2026 ($4,789 Mil) to Jun. 2026 ($8,088 Mil).
Hims & Hers Health's annual market cap
increased
from Dec. 2023 ($1,900 Mil) to Dec. 2024 ($5,340 Mil) and
increased
from Dec. 2024 ($5,340 Mil) to Dec. 2025 ($7,379 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Hims & Hers Health's Enterprise Value for Today is $7,170 Mil.
Hims & Hers Health (NYSE:HIMS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Hims & Hers Health Market Cap Related Terms
Hims & Hers Health Market Cap Historical Data
* Premium members only.
The historical data trend for Hims & Hers Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Hims & Hers Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hims & Hers Health Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hims & Hers Health's Market Cap distribution charts can be found below:
* The bar in red indicates where Hims & Hers Health's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Hims & Hers Health's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hims & Hers Health (HIMS) has a Market Cap of $6,465 Mil as of Sep. 06, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Hims & Hers Health and its competitors. According to the industry distribution chart, Hims & Hers Health ranks #69 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 6.7%.
Is Hims & Hers Health's Market Cap too high?
Hims & Hers Health's current Market Cap is $6,465 Mil. The Drug Manufacturers industry median Market Cap is 239.19. Hims & Hers Health's value of $6,465 Mil is 2602.9% above this industry median. Based on the distribution chart, Hims & Hers Health ranks #69 out of 1024 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Hims & Hers Health has a GF Score™ of 77/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's Market Cap compare to LNTH and AMRX?
According to the Drug Manufacturers industry distribution chart, Hims & Hers Health ranks #69 out of 1024 companies for Market Cap. This places Hims & Hers Health in the top 7% of its industry — outperforming the majority of peers. The industry median Market Cap is 239.19. Hims & Hers Health's value of $6,465 Mil is 2602.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 239.19, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hims & Hers Health's current Market Cap of $6,465 Mil is 2602.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Hims & Hers Health and its competitors. For the Drug Manufacturers industry, the median Market Cap is 239.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hims & Hers Health's current Market Cap is $6,465 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Based on GuruFocus' analysis, Hims & Hers Health (HIMS) is currently considered Possible Value Trap. The stock's GF Value™ is $43.93, compared to a current price of $27.71 — trading 36.9% below its estimated fair value. The current Market Cap is $6,465 Mil and 2602.9% above the Drug Manufacturers industry median of 239.19. Hims & Hers Health's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Hims & Hers Health (HIMS), the current Market Cap is $6,465 Mil as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hims & Hers Health (HIMS) Overvalued in 2026?
Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued.
The current stock price of $27.71 is trading 36.9% below its estimated GF Value™ of $43.93.
GuruFocus considers Hims & Hers Health to be Possible Value Trap.
Key valuation signals for HIMS:
Market Cap: $6,465 Mil
GF Value™: $43.93 vs. price of $27.71 (36.9% below fair value)
Industry Position: 2602.9% above the Drug Manufacturers median (#69 of 1024)
No single metric tells the full story. See the HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
77GF Score
Get the complete analysis for HIMS
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HIMS has been successfully added to your 
